Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
European Diabetes Insulin Pen Market Outlook 2022: Top 5 Countries - Key Players are Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford & Ypsomed | ||
By: PR Newswire Association LLC. - 22 Sep 2017 | Back to overview list |
|
DUBLIN, September 22, 2017 /PRNewswire/ -- The "Diabetes Insulin Pen Market Outlook 2022: Top 5 European Countries Opportunity and Demand Analysis, Market Forecast 2017 - 2022" report has been added to Research and Markets' offering. Diabetes Insulin Pen Market Outlook 2022: Top 5 European Countries Opportunity and Demand Analysis, Market Forecast 2017-2022 examines the market, demand, competitive landscape and trends of the top 5 European markets of the insulin pen market. It provides an all-round analysis of overall number of patients with diabetes and insulin users. It offers information on users of insulin pens, specifically focusing on reusable and prefilled insulin pen users. Market outlook in value terms for the forecasted period for insulin pen market has been detailed in the report. The report also explores detailed description of growth drivers and barriers of the insulin pen market. Market growth can be attributed to factors such as increasing number of patients with diabetes, high adoption rate, user-friendly design, surging popularity amid consumers, help avoid over/under-dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices. The report concludes with the profiles of major players in the insulin pen market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford and Ypsomed. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the insulin pen market. Long-term Growth Projection and Development:
Top 5 European Countries Covered in the Report Have Studied from 8 Viewpoints: For more information about this report visit https://www.researchandmarkets.com/research/3xpjjg/diabetes_insulin Media Contact: Laura Wood, Senior Manager View original content:http://www.prnewswire.com/news-releases/european-diabetes-insulin-pen-market-outlook-2022-top-5-countries---key-players-are-novo-nordisk-eli-lilly-sanofi-owen-mumford--ypsomed-300524313.html SOURCE Research and Markets |
||
|
||
Copyright 2017 PR Newswire Association LLC. | Back to overview list |